TY - JOUR
T1 - Clinical profile of patients with diabetic ketoacidosis and hyperglycemic hyperosmolar syndrome in Japan
T2 - a multicenter retrospective cohort study
AU - Takahashi, Kyosuke
AU - Uenishi, Norimichi
AU - Sanui, Masamitsu
AU - Uchino, Shigehiko
AU - Yonezawa, Naoki
AU - Takei, Tetsuhiro
AU - Nishioka, Norihiro
AU - Kobayashi, Hirotada
AU - Otaka, Shunichi
AU - Yamamoto, Kotaro
AU - Yasuda, Hideto
AU - Kosaka, Shintaro
AU - Tokunaga, Hidehiko
AU - Fujiwara, Naoki
AU - Kondo, Takashiro
AU - Ishida, Tomoki
AU - Komatsu, Takayuki
AU - Endo, Koji
AU - Moriyama, Taiki
AU - Oyasu, Takayoshi
AU - Hayakawa, Mineji
AU - Hoshino, Atsumi
AU - Matsuyama, Tasuku
AU - Miyamoto, Yuki
AU - Yanagisawa, Akihiro
AU - Wakabayashi, Tadamasa
AU - Ueda, Takeshi
AU - Komuro, Tetsuya
AU - Sugimoto, Toshiro
AU - Lefor, Alan Kawarai
N1 - Publisher Copyright:
© 2023, Springer-Verlag Italia S.r.l., part of Springer Nature.
PY - 2024/1
Y1 - 2024/1
N2 - Introduction: Diabetic ketoacidosis (DKA) and hyperglycemic hyperosmolar syndrome (HHS) are life-threatening complications of diabetes mellitus. Their clinical profiles have not been fully investigated. Methods: A multicenter retrospective cohort study was conducted in 21 acute care hospitals in Japan. Patients included were adults aged 18 or older who had been hospitalized from January 1, 2012, to December 31, 2016 due to DKA or HHS. The data were extracted from patient medical records. A four-group comparison (mild DKA, moderate DKA, severe DKA, and HHS) was performed to evaluate outcomes. Results: A total of 771 patients including 545 patients with DKA and 226 patients with HHS were identified during the study period. The major precipitating factors of disease episodes were poor medication compliance, infectious diseases, and excessive drinking of sugar-sweetened beverages. The median hospital stay was 16 days [IQR 10–26 days]. The intensive care unit (ICU) admission rate was 44.4% (mean) and the rate at each hospital ranged from 0 to 100%. The in-hospital mortality rate was 2.8% in patients with DKA and 7.1% in the HHS group. No significant difference in mortality was seen among the three DKA groups. Conclusions: The mortality rate of patients with DKA in Japan is similar to other studies, while that of HHS was lower. The ICU admission rate varied among institutions. There was no significant association between the severity of DKA and mortality in the study population. Trial Registration: This study is registered in the UMIN clinical Trial Registration System (UMIN000025393, Registered 23th December 2016).
AB - Introduction: Diabetic ketoacidosis (DKA) and hyperglycemic hyperosmolar syndrome (HHS) are life-threatening complications of diabetes mellitus. Their clinical profiles have not been fully investigated. Methods: A multicenter retrospective cohort study was conducted in 21 acute care hospitals in Japan. Patients included were adults aged 18 or older who had been hospitalized from January 1, 2012, to December 31, 2016 due to DKA or HHS. The data were extracted from patient medical records. A four-group comparison (mild DKA, moderate DKA, severe DKA, and HHS) was performed to evaluate outcomes. Results: A total of 771 patients including 545 patients with DKA and 226 patients with HHS were identified during the study period. The major precipitating factors of disease episodes were poor medication compliance, infectious diseases, and excessive drinking of sugar-sweetened beverages. The median hospital stay was 16 days [IQR 10–26 days]. The intensive care unit (ICU) admission rate was 44.4% (mean) and the rate at each hospital ranged from 0 to 100%. The in-hospital mortality rate was 2.8% in patients with DKA and 7.1% in the HHS group. No significant difference in mortality was seen among the three DKA groups. Conclusions: The mortality rate of patients with DKA in Japan is similar to other studies, while that of HHS was lower. The ICU admission rate varied among institutions. There was no significant association between the severity of DKA and mortality in the study population. Trial Registration: This study is registered in the UMIN clinical Trial Registration System (UMIN000025393, Registered 23th December 2016).
UR - http://www.scopus.com/inward/record.url?scp=85171585876&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85171585876&partnerID=8YFLogxK
U2 - 10.1007/s00592-023-02181-1
DO - 10.1007/s00592-023-02181-1
M3 - Article
C2 - 37728831
AN - SCOPUS:85171585876
SN - 0940-5429
VL - 61
SP - 117
EP - 126
JO - Acta Diabetologica
JF - Acta Diabetologica
IS - 1
ER -